Cover Image

Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Subjects:	Gene therapy > United States. Clinical trials > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112486

Similar Items

Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
Published: (2006)

Guidance for industry : guidance for human somatic cell therapy and gene therapy.
Published: (1998)

Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)

Guidance for industry : information program on clinical trials for serious or life-threatening diseases and conditions.
Published: (2002)

Guidance for industry : acceptance of foreign clinical studies.
Published: (2001)

Guidance for industry : E9 statistical principles for clinical trials.
Published: (1998)

Self-assembling complexes for gene delivery : from laboratory to clinical trial /
Published: (1998)

Guidance for industry : computerized systems used in clinical trials.
Published: (1999)

Guidance for industry : collection of race and ethnicity data in clinical trials.
Published: (2005)

Guidance for clinical trial sponsors : establishment and operation of clinical trial data monitoring committees.
Published: (2006)

Guidance for industry : independent consultants for biotechnology clinical trial protocols.
Published: (2004)

Guidance for industry : submitting and reviewing complete responses to clinical holds.
Published: (2000)

Gene therapy of cancer /
Published: (1998)

Guidance for industry : M4S, the CTD, safety.
Published: (2001)

Guidance for industry : M4S, the CTD, safety appendices.
Published: (2001)

Guidance for industry : potency tests for cellular and gene therapy products.
Published: (2008)

Guidance for industry : postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic Act.
Published: (2009)

Gene therapy : status, prospects for the future, and government policy implications : hearing before the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, second session, September 28, 1994.
Published: (1995)

Implementing a national cancer clinical trials system for the 21st century : workshop summary /
Published: (2011)

Guidance for clinical investigators, sponsors, and IRBs : adverse event reporting to IRBs : improving human subject protection.
Published: (2009)

Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)

Guidance for industry : IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.
Published: (2004)

Guidance for industry : M4Q, the CTD, quality.
Published: (2001)

Guidance for industry : E6 good clinical practice, consolidated guidance.
Published: (1996)

Guidance for industry : toxicity grading schedule for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials.
Published: (2007)

Reviewer guidance : conducting a clinical safety review of a new product application and preparing a report on the review.
Published: (2005)

Improving the quality of cancer clinical trials : workshop summary /
Published: (2008)

Guidance for industry : M4E, the CTD, efficacy.
Published: (2001)

Gene therapy : is there oversight for patient safety? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... February 2, 2000.
Published: (2000)

Gene therapy : are patients any safer? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... May 25, 2000.
Published: (2000)

Guidance for industry : computerized systems used in clinical investigations.
Published: (2007)

Guidance for industry : validation of growth-based rapid microbiological methods for sterility testing of cellular and gene therapy products.
Published: (2008)

Clinical trials roadmap for physician practices /
by: Morgan, Christie L.
Published: (2004)

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs).
Published: (2008)

Clinical drug trials and tribulations /
Published: (1988)

Guideline for the monitoring of clinical investigations.
Published: (1988)

A national cancer clinical trials system for the 21st century : reinvigorating the NCI cooperative group program /
Published: (2010)

Guidance for clinical investigators, institutional review boards, and sponsors : process for handling referrals to FDA under 21 CFR 50.54 : additional safeguards for children in clinical investigations.
Published: (2006)

Behandlungsversuche bei Psittakose des Nymphensittichs (Nymphicus hollandicus) /
by: Zeh, Christa (Christa Hannelore), 1947-
Published: (1976)

A first-order characterization of clinical trials /
by: Hopwood, Marsha
Published: (1980)